Effectiveness analysis of clinical pharmacists intervention in the clinical application of piperacillin-tazobactam based on PDCA
10.12206/j.issn.1006-0111.202002088
- VernacularTitle:临床药师基于PDCA干预哌拉西林他唑巴坦临床应用的成效分析
- Author:
Yafen DONG
1
;
Jian WANG
1
;
Wenjun ZHU
1
;
Qiaoyan CUI
1
;
Helong LIU
1
;
Yan QIU
1
Author Information
1. Shanghai Pudong New Area People's Hospital, Shanghai 201200, China.
- Keywords:
piperacillin-tazobactam;
PDCA cycle;
rational drug use
- From:
Journal of Pharmaceutical Practice
2020;38(6):574-576
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of the intervention of clinical pharmacists on the rational use of piperacillin-tazobactam by using PDCA cycle, in order to provide reference for rational drug use. Methods The problems of piperacillin-tazobactam in our hospital was analyzed. PDCA cycle was used to manage the problems. Then, the data before and after PDCA cycle was compared and analyzed. Results After using PDCA cycle, the irrational use rate of piperacillin-tazobactam gradually decreased, from 9% in February 2018 to 2% in February 2019; the doses decreased from 4380 in February 2018 to 3346 in February 2019; and the frequency of usage decreased from 391 DDDs in February 2018 to 298 DDDs in February 2019. The effectiveness and continuous improvement of PDCA cycle in managing piperacillin-tazobactam were significant. Conclusion PDCA cycle can effectively improve the management effectiveness of piperacillin-tazobactam administration.
